3Ationu A. Carbamylation and glycosy1ation of haemoglobin in vitro: effects of cyanate and glucose. Med Lab Sci 1992;49(1):34-37.
4Gillette P,Manning JW, Cerami A Increased Surrival of sickle cell eryghrocytes ofter treatment in vitro with sodium eyanate. Proc Natl Acad Sci USA ,1971,68:2791-2793.
5Smith WG, Holden M, Benton M,et al. Carbamylated haemoglobin in chronic renal failure. : Clin Chim Acta 1988;178(3):297-303.
6Kwan JT, Carr EC, Bending MR, et al. Determination of carbamylated hemoglobin by high-per-formance liquid chromatography. Clin Chem 1990;36(4):607-610:
7Kwan JT, Carr EC, Barron JL, et al. Carbamylated haemoglobin--a retrospective index of timeaveraged urea concentration. Nephrol Dial Transplant 1993;8(6):565-567.
8Kairaitis LK, Yuill E, Harris DC,Determinants of haemoglobin carbamylation in haemodialysis and peritoneal dialysis patients. Nephrol Dial Transplant 2000;15(9):1431-1437.
9Weykamp CW, Miedema K, de Haan T, Carbamylated hemoglobin interference in glycohemoglobin assays., Clin Chem , 1999;45(3):438-440.
10Davenport A, Jones S, Goel S,et al. Carbamylated hemoglabin :apotential marketfort theadequacof hemodialysis the rapyinedd stagerenal failure ,Kidey Int,1996,50:1344-1351.
